SAN ANTONIO, TX, June 9, 2026 – Texas Biomedical Research Institute, one of the world’s leading independent biomedical research institutions, is working with its global partners to test therapies and preventatives for the ongoing outbreak caused by the virus in the Democratic Republic of the Congo (DRC) and Uganda.
Texas Biomed is working on several studies to evaluate preclinical therapies against Bundibugyo virus disease, the severe and often fatal form of Ebola that was first reported in DRC to the World Health Organization in early May. Global health authorities have cautioned that no tally is accurate, but that there are likely more than 1,000 suspected cases and more than 250 deaths as of early June.
“Ebola remains one of the world’s most dangerous infectious diseases and with the current outbreak, poses a significant global health threat,” said Cory Hallam, Ph.D., Executive Vice President of Applied Science and Innovation at Texas Biomed. “Our collaborations with industry and biotech companies to try and bring resources to this outbreak reflect the critical and nimble role that Texas Biomed plays in responding to emerging infectious disease threats. We are proud to help advance tools that have the potential to protect communities and save lives.”
Texas Biomed brings together a combination of scientific expertise, specialized high-containment facilities and a proven track record evaluating infectious disease countermeasures, making it an invaluable partner. It is the only private biomedical research institute in the world with both a National Primate Research Center and a biosafety level 4 (BSL-4) laboratory.
About Texas Biomedical Research Institute
Texas Biomed is a nonprofit research institute dedicated to protecting the global community from infectious diseases. Through basic research, preclinical testing and innovative partnerships, we accelerate diagnostics, therapies and vaccines for the world’s deadliest pathogens. Our San Antonio campus hosts high containment laboratories and the Southwest National Primate Research Center. Our scientists collaborate with industry and researchers globally and have helped deliver the first COVID-19 vaccine, the first Ebola treatment and first Hepatitis C therapy. For more information, please visit https://txbiomed.org or follow Texas Biomed on LinkedIn.